Human Longevity
Human Longevity Raises $39.8M in Second Series B Financing Round
The concierge care and precision medicine firm has now raised over $369.8 million since its founding in 2013.
A spinoff of personalized health company Human Longevity, Simplify Genomics came out of stealth mode last month and is currently "hyperfocused" on the concierge health market.
Human Longevity to Go Public Through $345M SPAC Merger
HLI and special purpose acquisition company Freedom Acquisition I claimed the transaction values the proposed combined company at approximately $1 billion.
Whole-Genome Sequencing, Deep Phenotyping Shows Many Adults Harbor Pathogenic Genetic Variants
The study, led by researchers from precision health firm Human Longevity, also uncovered phenotypic evidence supporting some pathogenic genetic findings.
NeoGenomics Acquires Human Longevity's Oncology Division for $37M
The oncology division of Human Longevity performs next-generation sequencing services for pharmaceutical customers and generated $10 million in revenue in 2019.